Article
Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses.
Nature medicine - 1 Jul 2023
Als Thomas D, Kurki Mitja I, Grove Jakob, Voloudakis Georgios, Therrien Karen, Tasanko Elisa, Nielsen Trine Tollerup, Naamanka Joonas, Veerapen Kumar, Levey Daniel F, Bendl Jaroslav, Bybjerg-Grauholm Jonas, Zeng Biao, Demontis Ditte, Rosengren Anders, Athanasiadis Georgios, Bækved-Hansen Marie, Qvist Per, Bragi Walters G, Thorgeirsson Thorgeir, Stefánsson Hreinn, Musliner Katherine L, Rajagopal Veera M, Farajzadeh Leila, Thirstrup Janne, Vilhjálmsson Bjarni J, McGrath John J, Mattheisen Manuel, Meier Sandra, Agerbo Esben, Stefánsson Kári, Nordentoft Merete, Werge Thomas, Hougaard David M, Mortensen Preben B, Stein Murray B, Gelernter Joel, Hovatta Iiris, Roussos Panos, Daly Mark J, Mors Ole, Palotie Aarno, Børglum Anders D
Abstract excerpt
Depression is a common psychiatric disorder and a leading cause of disability worldwide. Here we conducted a genome-wide association study meta-analysis of six datasets, including >1.3 million individuals (371,184 with depression) and identified 243 risk loci. Overall, 64 loci were new, including genes encoding glutamate and GABA receptors, which are targets for antidepressant drugs. Intersection with functional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
